共 77 条
[1]
Carratala J(2007)Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy and clinical outcomes Arch Intern Med 167 1393-1399
[2]
Mykietiuk A(2007)Healthcare-associated pneumonia and community-acquired pneumonia: a single center experience Antimicrob Agents Chemother 51 3568-3573
[3]
Fernandez-Sabe N(2011)Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Eur Respir J 38 878-887
[4]
Micek ST(2010)Healthcare-associated pneumonia ( Am J Respir Crit Care Med 181 A3212-1210
[5]
Kollef KE(2012)): clinical features and biomarkers Eur Respir J 40 1201-12
[6]
Reichley RM(2012)Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Swiss Med Wkly 142 w13542-951
[7]
Attridge RT(2009)Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia Crit Care 13 156-666
[8]
Frei CR(2011)ICU admission and severity assessment in community-acquired pneumonia J Clin Virol 50 8-2735
[9]
Restrepo MI(2007)High plasma mid-regional proadrenomedullin levels in children with severe dengue virus infections Thromb Haemost 98 944-1155
[10]
Polverino E(2006)Adrenomedullin and endothelial barrier function Peptides 27 661-1454